The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ($CVS) and Cigna ...
However, its low valuation could have investors wondering if now is the right time to take a chance on the business, ...
Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...
Walgreens Boots Alliance ( WBA 1.03%) and CVS Health ( CVS 2.86%) face uncertain paths forward. They have both undergone ...
Evercore ISI raised the firm’s price target on CVS Health (CVS) to $65 from $60 and keeps an Outperform rating on the shares. Given 2025 will ...
CVS notified Susan Fracasso, rapid response coordinator for the state Department of Labor and Hartford Mayor Arunan ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback